sciencedaily.com
CRISPR could help doctors attack blood cancer without destroying healthy cells
A new Phase 1/2 clinical trial involving 30 patients demonstrates that genetically modifying donor stem cells with CRISPR to remove the CD33 protein can allow targeted cancer therapies to attack aggre
